Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
Company Details
- Employees
- 128
- Founded
- -
- Address
- 129 N Hill Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- terraytherapeutics.com
- Keywords
- Engineer jobs.
- HQ
- Pasadena, California
Terray Therapeutics Questions
Terray Therapeutics's website is terraytherapeutics.com
Terray Therapeutics's LinkedIn profile is https://www.linkedin.com/company/terray-therapeutics
Terray Therapeutics has
128 employees.
View email and phone details for 128
employees at Terray Therapeutics.
Terray Therapeutics's industry is
Biotechnology Research
Terray Therapeutics's top competitors are
Aktis Oncology,
Aspect Biosystems,
Atbtherapeutics,
City Therapeutics,
Avencell,
A2 Biotherapeutics, Inc.,
Triveni Bio,
Seaport Therapeutics,
Atalanta Therapeutics,
Kailera Therapeutics.
Terray Therapeutics's categories are Biotechnology Research
Terray Therapeutics's founding year is 2018
